Modifying the Medical Research Council grading system through Rasch analyses
暂无分享,去创建一个
Alan Tennant | Giuseppe Lauria | L. H. van den Berg | A. Tennant | G. Lauria | D. Cornblath | B. Jacobs | A. J. van der Kooi | P. V. van Doorn | C. Faber | R. van Koningsveld | J. Engelsman | Els Karla Vanhoutte | Catharina Gerritdina Faber | Sonja Ingrid van Nes | Bart Casper Jacobs | Pieter Antoon van Doorn | Rinske van Koningsveld | David Reid Cornblath | Anneke Jelly van der Kooi | Elisabeth Aviva Cats | Leonard Hendrik van den Berg | Nicolette Claudia Notermans | Willem Lodewijk van der Pol | Mieke Catharina Elisabeth Hermans | Nadine Anna Maria Elisabeth van der Beek | Kenneth Craig Gorson | Marijke Eurelings | Jeroen Engelsman | Hendrik Boot | Ronaldus Jacobus Meijer | Ingemar Sergio José Merkies | N. Notermans | E. Vanhoutte | E. A. Cats | K. Gorson | M. Eurelings | M. Hermans | S. I. van Nes | I. Merkies | W. L. van der Pol | N. M. van der Beek | Hendrik Boot | R. Meijer | E. Cats | M. C. Hermans | Nadine Anna Maria Elisabeth van der Beek
[1] P. Schmitz,et al. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain‐Barré syndrome , 1991, Muscle & nerve.
[2] R. Hughes,et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy * , 2006, European journal of neurology.
[3] M. Bakkers,et al. Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies , 2011, Neurology.
[4] April. AIDS TO THE INVESTIGATION OF PERIPHERAL NERVE INJURIES , 1943 .
[5] P. Schmitz,et al. A randomized trial comparing intravenous immunoglobulin and plasma exchange in Guillain-Barré syndrome. , 1994, Transfusion science.
[6] Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP) , 1991, Neurology.
[7] E. Svensson. Guidelines to statistical evaluation of data from rating scales and questionnaires. , 2001, Journal of rehabilitation medicine.
[8] J. Gabriel,et al. Paraproteinaemic Neuropathies , 1999, Bailliere's clinical neurology.
[9] Education Division. Studies in social psychology in World War II , 1949 .
[10] S. Cuthbert,et al. On the reliability and validity of manual muscle testing: a literature review , 2007, Chiropractic & osteopathy.
[11] E. Nobile‐Orazio. IgM paraproteinaemic neuropathies , 2004, Current opinion in neurology.
[12] H. Smeets,et al. Age and causes of death in adult-onset myotonic dystrophy. , 1998, Brain : a journal of neurology.
[13] D. Altman,et al. Statistics notes: Cronbach's alpha , 1997 .
[14] D. Green,et al. Critical reappraisal of Medical Research Council muscle testing for elbow flexion. , 2007, The Journal of hand surgery.
[15] M H Liang,et al. Evaluating measurement responsiveness. , 1995, The Journal of rheumatology.
[16] Julie F Pallant,et al. An introduction to the Rasch measurement model: an example using the Hospital Anxiety and Depression Scale (HADS). , 2007, The British journal of clinical psychology.
[17] M Penta,et al. The ABILHAND Questionnaire as a Measure of Manual Ability in Chronic Stroke Patients: Rasch-Based Validation and Relationship to Upper Limb Impairment , 2001, Stroke.
[18] I. Merkies. Evaluation of scales and measurement instruments in immune-mediated polyneuropathies , 2001 .
[19] L. H. van den Berg,et al. Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment. , 2002, Brain : a journal of neurology.
[20] Ruud W Selles,et al. Strength measurements of the intrinsic hand muscles: a review of the development and evaluation of the Rotterdam intrinsic hand myometer. , 2006, Journal of hand therapy : official journal of the American Society of Hand Therapists.
[21] S. Stouffer,et al. Measurement and Prediction , 1954 .
[22] J. Meulstee,et al. Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial , 2004, The Lancet.
[23] P. Bergh,et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision , 2010, Journal of the peripheral nervous system : JPNS.
[24] Catharina G. Faber,et al. Rasch-built myotonic dystrophy type 1 activity and participation scale (DM1-Activ) , 2010, Neuromuscular Disorders.
[25] Treatment of Guillain‐Barré syndrome with high‐dose immune globulins combined with methylprednisolone: A pilot study , 1994, Annals of neurology.
[26] Jean-Louis Thonnard,et al. ACTIVLIM: A Rasch-built measure of activity limitations in children and adults with neuromuscular disorders , 2007, Neuromuscular Disorders.
[27] J. Beckmann,et al. 30th and 31st ENMC international workshops, Naarden, The Netherlands, Held 6–8 January 1995 , 1995, Neuromuscular Disorders.
[28] R. Devellis. Classical Test Theory , 2006, Medical care.
[29] Alan Tennant,et al. The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? , 2007, Arthritis and rheumatism.
[30] L. Merlini. Measuring muscle strength in clinical trials , 2010, The Lancet Neurology.
[31] J. Thonnard,et al. Assessing and Adjusting for Cross-Cultural Validity of Impairment and Activity Limitation Scales Through Differential Item Functioning Within the Framework of the Rasch Model: The PRO-ESOR Project , 2004, Medical care.
[32] R. Oostendorp,et al. Manual muscle strength testing: intraobserver and interobserver reliabilities for the intrinsic muscles of the hand. , 1995, Journal of hand therapy : official journal of the American Society of Hand Therapists.
[33] T. Prior. Technical standards and guidelines for myotonic dystrophy type 1 testing , 2009, Genetics in Medicine.
[34] John M Linacre,et al. Optimizing rating scale category effectiveness. , 2002, Journal of applied measurement.
[35] F. Bombelli,et al. Multifocal motor neuropathy , 2013, Current opinion in neurology.
[36] W. Hop,et al. Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients. , 2005, Brain : a journal of neurology.
[37] P. Schmitz,et al. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. , 1992, The New England journal of medicine.
[38] D. Cornblath,et al. Assessment of current diagnostic criteria for Guillain‐Barré syndrome , 1990, Annals of neurology.
[39] A. Windebank,et al. History of standard scoring, notation, and summation of neuromuscular signs. A current survey and recommendation , 2005, Journal of the peripheral nervous system : JPNS.
[40] J. Linacre,et al. Sample size and item calibration stability , 1994 .
[41] European Federation of Neurological Societies/Peripheral Nerve Society Guideline * on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society , 2006, Journal of the peripheral nervous system : JPNS.
[42] Alan Tennant,et al. Application of Rasch analysis in the development and application of quality of life instruments. , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[43] Georg Rasch,et al. Probabilistic Models for Some Intelligence and Attainment Tests , 1981, The SAGE Encyclopedia of Research Design.
[44] Everett V. Smith. Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residuals. , 2002, Journal of applied measurement.
[45] S. Weir Mitchell,et al. THE TENDON-JERK AND MUSCLE-JERK IN DISEASE, AND ESPECIALLY IN POSTERIOR SCLEROSIS1 , 1886 .
[46] J. Beckmann,et al. The limb-girdle muscular dystrophies--proposal for a new nomenclature. , 1995, Neuromuscular disorders : NMD.
[47] G. van Ommen,et al. The clinical spectrum of limb girdle muscular dystrophy. A survey in The Netherlands. , 1996, Brain : a journal of neurology.
[48] H. Hartung,et al. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial , 2008, The Lancet Neurology.